Table 2.
Statistical significance of prognostic value of EZH2 in various cancer types.
| Cancer Type | p |
|---|---|
| Bladder urothelial carcinoma | 0.726 |
| Breast invasive carcinoma | 0.402 |
| Cervical squamous cell carcinoma | 0.293 |
| Colon adenocarcinoma | 0.333 |
| Esophageal carcinoma | 0.837 |
| Glioblastoma multiforme | 0.994 |
| Head and neck squamous cell carcinoma | 0.183 |
| Kidney renal clear cell carcinoma | <0.001 * |
| Kidney renal papillary cell carcinoma | 0.00794 * |
| Acute myeloid leukemia | 0.378 |
| Brain lower grade glioma | 0.00212 * |
| Liver hepatocellular carcinoma | <0.001 * |
| Lung adenocarcinoma | 0.476 |
| Lung squamous cell carcinoma | 0.0946 |
| Ovarian serous cystadenocarcinoma | 0.526 |
| Pancreatic adenocarcinoma | 0.145 |
| Rectum adenocarcinoma | 0.959 |
| Sarcoma | 0.415 |
| Skin cutaneous melanoma | 0.182 |
| Stomach adenocarcinoma | 0.0874 |
| Uterine corpus endometrial carcinoma | 0.144 |
* p < 0.05.